Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Uveitis in Behçet's disease

R B Nussenblatt1

  • 1Laboratory of Immunology, National Eye Institute, NIH, Bethesda, MD 20892, USA.

International Reviews of Immunology
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Behçet's disease causes recurrent, sight-threatening eye inflammation. Early diagnosis and systemic treatment are crucial for managing ocular complications and preventing vision loss.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunopathology of ocular onchocerciasis 3. Th-2 helper T cells in the conjunctiva.

Ocular immunology and inflammation·2012
Same author

Association of Propionibacterium acnes endophthalmitis with HLA-DQw5.

Ocular immunology and inflammation·2012
Same author

Clinical pathologic findings of Propionibacterium acnes endophthalmitis.

Ocular immunology and inflammation·2012
Same author

Inflammatory cellular kinetics in sympathetic ophthalmia a study of 29 traumatized (exciting) eyes.

Ocular immunology and inflammation·2012
Same author

Inhibition of cellular transfer of experimental autoimmune uveoretinitis by Rapamycin.

Ocular immunology and inflammation·2012
Same author

Immunohistochemical localization of T lymphocytes and macrophages and expression of interferon gamma and defensin in uveitis.

Ocular immunology and inflammation·2012
Same journal

Leptin in metabolic-immune crosstalk: Mechanisms of T cell regulation and implications for autoimmune disease therapy.

International reviews of immunology·2026
Same journal

Metabolic alterations in the tumor microenvironment influence the anti-tumor immune function of CD8<sup>+</sup> T cells via epigenetic modifications.

International reviews of immunology·2026
Same journal

Macrophage markers and gene signature profiling reveals mesenchymal stem cells mediated immune modulation in Plasmodium berghei ANKA infection.

International reviews of immunology·2026
Same journal

Natural antigen landscape shaping intestinal Treg cells: Self, diet, and microbiota.

International reviews of immunology·2026
Same journal

Upregulation of ADAM10 reinforces CD8<sup>+</sup> T cells toward exhaustion in the TME.

International reviews of immunology·2026
Same journal

PTX3 promotes macrophage efferocytosis and inflammation resolution in granulomatous mastitis.

International reviews of immunology·2026
See all related articles

Area of Science:

  • Ophthalmology
  • Rheumatology
  • Immunology

Background:

  • Behçet's disease is a multisystem inflammatory disorder.
  • Ocular complications are a major diagnostic criterion and can be sight-threatening.
  • Ocular inflammation in Behçet's disease presents as recurrent, explosive attacks.

Purpose of the Study:

  • To review the ocular complications of Behçet's disease.
  • To highlight the diagnostic importance and management strategies for ocular involvement.
  • To emphasize the sight-threatening nature of recurrent retinal vaso-occlusive disease.

Main Methods:

  • Review of literature on Behçet's disease and its ocular manifestations.
  • Analysis of clinical presentations, diagnostic criteria, and treatment outcomes.

Related Experiment Videos

  • Discussion of inflammatory mechanisms and potential complications.

    • Main Results:

    • Anterior segment involvement, often severe uveitis with hypopyon, typically has a good visual outcome with topical treatment.
    • Posterior segment involvement, particularly recurrent retinal vaso-occlusive disease, is sight-threatening.
    • Complications include retinal and optic atrophy, vitreous hemorrhage, neovascular glaucoma, and retinal detachment.

    Conclusions:

    • Ocular complications of Behçet's disease require vigilant monitoring and prompt management.
    • Systemic immunosuppressive therapy is essential for managing sight-threatening posterior segment disease.
    • Multidisciplinary care is vital for optimizing visual outcomes in patients with Behçet's disease.